H
HighLife
France · Healthtech · Hardware
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
Product
HighLife Medical develops a transcatheter mitral-valve replacement system delivered through a transfemoral approach. The company describes a valve-in-ring design for structural-heart teams treating severe mitral regurgitation.
HighLife is advancing clinical and regulatory development, including a planned U.S. pivotal study and European commercialization.
- Product focus
- Transcatheter mitral valve replacement
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Financing round | €80M | Andera Partners — LeadMérieux Equity Partners — LeadSofinnova Partners — LeadSupernova Invest — LeadBNP Paribas Développement — ParticipantCapricorn Partners — ParticipantCritical Path Ventures — ParticipantEuropean Investment Bank — ParticipantPro Benefis Familiae — ParticipantSectoral — ParticipantSPRIM Global Investments Ltd. — ParticipantUSVP — ParticipantVI Partners — Participant |